Insider · CIK 0001798117

Norry Elliot

Reports to the SEC for 1 company · ABINGDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001798117

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+1.61M sh	—	—	1,612,032
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+1.07M sh	—	—	1,074,696
2025-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−5,584 sh	$0.58	−$3,243.187	7,510
2025-01-15	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−9,803 sh	$0.57	−$5,634.764	13,756
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−4,268 sh	$0.59	−$2,509.157	5,845
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−8,124 sh	$0.59	−$4,776.1	11,516
2024-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−5,309 sh	$0.67	−$3,572.957	7,785
2024-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−13K sh	$0.67	−$8,726.791	19,257
2024-01-16	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−2,287 sh	$0.79	−$1,806.73	3,363
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+2.54M sh	—	—	2,544,432
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+565K sh	—	—	565,416
2024-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−7,799 sh	$0.85	−$6,661.126	11,841
2024-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−4,009 sh	$0.84	−$3,354.33	6,104
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+1.41M sh	—	—	1,407,072
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+314K sh	—	—	314,256
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+193K sh	—	—	193,344
2023-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−2,159 sh	$1.86	−$4,011.422	3,491
2023-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−7,449 sh	$1.71	−$12.7K	12,191
2023-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−3,843 sh	$1.75	−$6,712.952	6,270
2023-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−876 sh	$1.69	−$1,483.944	1,361
2022-01-18	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−2,121 sh	$3.19	−$6,769.808	3,529
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+2.11M sh	—	—	2,110,608
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+471K sh	—	—	471,360
2022-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−854 sh	$3.54	−$3,026.661	1,383
2022-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−3,770 sh	$3.56	−$13.4K	6,343
2022-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−849 sh	$4.06	−$3,450.506	1,388
2021-01-19	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−2,111 sh	$5.67	−$12K	3,539
2021-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−841 sh	$6.15	−$5,174	1,396
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+1.09M sh	—	—	1,086,816
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+243K sh	—	—	242,712
2021-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−845 sh	$5.33	−$4,502.076	1,392
2020-01-16	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+202K sh	—	—	201,600
2020-01-16	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Chief Medical Officer	AAward	+136K sh	—	—	135,600
2020-01-14	ADAPAdaptimmune Therapeutics PLCS Sale	Chief Medical Officer	SSale	−911 sh	$5.13	−$4,677.712	1,326

Recent filings

Accepted (ET)
Feb 204
Norry Elliot0001104659-25-015741
SEC(opens sec.gov)
Jan 174
Norry Elliot0001104659-25-004608
SEC(opens sec.gov)
Jan 154
Norry Elliot0001104659-25-003771
SEC(opens sec.gov)
Jan 174
Norry Elliot0001104659-24-004523
SEC(opens sec.gov)
Jan 174
Norry Elliot0001104659-24-004563
SEC(opens sec.gov)
Jan 124
Norry Elliot0001104659-24-003743
SEC(opens sec.gov)
Jan 174
Norry Elliot0001104659-23-004371
SEC(opens sec.gov)
Jan 174
Norry Elliot0001104659-23-004380
SEC(opens sec.gov)
Jan 124
Norry Elliot0001104659-23-003535
SEC(opens sec.gov)
Jan 44
Norry Elliot0001104659-23-001089
SEC(opens sec.gov)

Companies

Adaptimmune Therapeutics PLCChief Medical OfficerADAP

Address

C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVENUE, MILTON PARK

ABINGDON, X0, OX14 4RX